SEMINAR: DEVELOPABILITY ASSESSMENT OF THERAPEUTIC ANTIBODIES - A CONCEPT FOR EARLY LEAD SELECTION | THORSTEN LORENZ, PHD - NOVARTIS PHARMA AG

31 May 16 iBET|ITQB Auditorium, Oeiras